Panel Discussion: Evaluating the Impact of Newborn Sequencing

28 Jan 2026
Women & Children's Health Stage
  • Introduction to the potential of newborn sequencing at birth.  

  • Overview of recent progress in newborn sequencing and the impact it is bringing to patients.  

  • Evaluating the clinical utility and implementation of relevant programmers e.g. prioritising different genetic variants and decision making processes. 

  • Challenges e.g. ethical considerations and false positives.  

  • Socioeconomic drivers and impact

Speakers
Melissa Hill
Melissa Hill, Senior Social Scientist - Great Ormond Street Hospital
James Buchanan
James Buchanan, Senior Lecturer, Health Economics and Policy Research Unit -  Queen Mary University London
Joachim Tan
Joachim Tan, Senior Research Fellow in Health Data Science -  UCL Great Ormond Street Institute of Child Health